Inovio Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Inovio Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-0.89 | $-1.13 | 21.2 % |
Q2 | 2024-08-08 | $-1.19 | $-1.10 | -8.18 % |
Q1 | 2024-05-13 | $-1.31 | $-1.00 | -31.0 % |
Q4 | 2024-03-06 | $-1.10 | $-1.27 | 13.4 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $0 | $104.50K | -100.0 % |
Q2 | 2024-08-08 | $100.76K | $120.00K | -16.0 % |
Q4 | 2024-03-06 | $103.00K | $340.00K | -69.7 % |
Q3 | 2023-11-09 | $388.45K | $120.00K | 223.7 % |
Inovio Pharmaceuticals (INO) is scheduled to report earnings on March 5, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.89, which beat the estimate of $-1.13.
The Actual Revenue was $0K, which missed the estimate of $104.5K.
Browse earnings estimates, EPS, and revenue on all stocks.